diallyl trisulfide has been researched along with Disease Exacerbation in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Banik, NL; Das, A; Dixon-Mah, YN; Giglio, P; Haar, CP; Patel, SJ; Ray, SK; Vandergrift, WA; Varma, AK; Wallace, GC | 1 |
| Armogida, C; Botti, G; Bucci, M; Cirino, G; De Cicco, P; Germano, D; Gigantino, V; Ianaro, A; Napolitano, M; Panza, E; Papapetropoulos, A; Scognamiglio, G | 1 |
2 other study(ies) available for diallyl trisulfide and Disease Exacerbation
| Article | Year |
|---|---|
Multi-targeted DATS prevents tumor progression and promotes apoptosis in ectopic glioblastoma xenografts in SCID mice via HDAC inhibition.
Topics: Allyl Compounds; Analysis of Variance; Animals; Apoptosis; Apoptosis Regulatory Proteins; Brain Neoplasms; Cell Line, Tumor; Disease Models, Animal; Disease Progression; Gene Expression Regulation, Neoplastic; Glioblastoma; Histone Deacetylases; Humans; In Situ Nick-End Labeling; Liver; Mice; Mice, SCID; Sulfides; Xenograft Model Antitumor Assays | 2013 |
Role of the cystathionine γ lyase/hydrogen sulfide pathway in human melanoma progression.
Topics: Allyl Compounds; Animals; Apoptosis; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Proliferation; Cystathionine beta-Synthase; Cystathionine gamma-Lyase; Disease Progression; Down-Regulation; Female; Gene Expression Regulation, Neoplastic; Gene Silencing; Humans; Hydrogen Sulfide; Melanoma; Mice, Inbred C57BL; Neoplasm Metastasis; Nevus; NF-kappa B; Signal Transduction; Skin Neoplasms; Sulfides; Sulfurtransferases | 2015 |